No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ASPN240719C25000
- 2.35
- +0.70+42.42%
15min DelayClose Jul 12 15:59 ET
2.40High1.67Low
1.80Open1.65Pre Close306 Volume1.82K Open Interest25.00Strike Price58.15KTurnover88.33%IV0.40%PremiumJul 19, 2024Expiry Date2.24Intrinsic Value100Multiplier7DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type0.7774Delta0.0884Gamma10.00Leverage Ratio-0.0741Theta0.0036Rho7.77Eff Leverage0.0114Vega
Intraday
- 5D
- Daily
News
Craig-Hallum Reaffirms Their Buy Rating on Aspen Aerogels (ASPN)
3 Momentum Anomaly Stocks to Buy as Rate Cut Odds Increase
Over the past few trading days, the broader U.S. equity markets have been trading at record highs buoyed by optimism related to rate cuts driven by easing inflationary pressures and an uptick in the unemployment rate.
Investors Appear Satisfied With Aspen Aerogels, Inc.'s (NYSE:ASPN) Prospects
When close to half the companies in the Chemicals industry in the United States have price-to-sales ratios (or "P/S") below 1.4x, you may consider Aspen Aerogels, Inc. (NYSE:ASPN) as a stock to avoid
Royce Micro-Cap Trust (NYSE: RMT) as of May 31, 2024
NEW YORK, June 24, 2024 /PRNewswire/ -- Average weekly trading volume of approximately 392,673 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PR
(ASPN) - Analyzing Aspen Aerogels's Short Interest
Aspen Aerogels's (NYSE:ASPN) short percent of float has fallen 17.59% since its last report. The company recently reported that it has 3.70 million shares sold short, which is 6.7% of all regular shar
Unprofitable Growth Stocks With a Path to Profitability - GS
Comments
$Aspen Aerogels(ASPN.US$ Hold until 30$.
#ASPN up over $16.50 a share, trying to decide if to pull the trigger and sell or hold for a little longer.
3
$Aspen Aerogels(ASPN.US$ let's gp
2
Aspen Aerogels' high P/S ratio is backed by strong revenue growth, outpacing the Chemicals industry. Investors' confidence in future revenues supports the high P/S ratio and share price. Yet, the company's prospects shouldn't be judged solely on the P/S ratio.
Aspen Aerogel's high P/S ratio is echoed by strong revenue growth, surpassing industry standard. With impressive growth forecasts exceeding industry estimates, the high P/S ratio is justifiable. The stock's rising trend indicates shareholders foresee continued outperformance, with no sharp drop in share price anticipated soon.
Read more